Search Results

There are 9329 results for: content related to: Effects of J anus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis

  1. You have free access to this content
    2017 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 69, Issue S10, October 2017, Pages: 1–4481,

    Version of Record online : 27 SEP 2017, DOI: 10.1002/art.40321

  2. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  3. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  4. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  5. You have free access to this content
    Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 617–629, Roy Fleischmann, Maurizio Cutolo, Mark C. Genovese, Eun Bong Lee, Keith S. Kanik, Seth Sadis, Carol A. Connell, David Gruben, Sriram Krishnaswami, Gene Wallenstein, Bethanie E. Wilkinson and Samuel H. Zwillich

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.33383

  6. You have free access to this content
    Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four–month phase III randomized radiographic study

    Arthritis & Rheumatism

    Volume 65, Issue 3, March 2013, Pages: 559–570, Désirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, Edward Keystone, Joel Kremer, Cristiano Zerbini, Mario H. Cardiel, Stanley Cohen, Peter Nash, Yeong-Wook Song, Dana Tegzová, Bradley T. Wyman, David Gruben, Birgitta Benda, Gene Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, John D. Bradley, Carol A. Connell and and the ORAL Scan Investigators

    Version of Record online : 25 FEB 2013, DOI: 10.1002/art.37816

  7. You have free access to this content
    A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 970–981, Joel M. Kremer, Stanley Cohen, Bethanie E. Wilkinson, Carol A. Connell, Jonathan L. French, Juan Gomez-Reino, David Gruben, Keith S. Kanik, Sriram Krishnaswami, Virginia Pascual-Ramos, Gene Wallenstein and Samuel H. Zwillich

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.33419

  8. You have free access to this content
    The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells

    Arthritis & Rheumatism

    Volume 64, Issue 6, June 2012, Pages: 1790–1798, Keisuke Maeshima, Kunihiro Yamaoka, Satoshi Kubo, Kazuhisa Nakano, Shigeru Iwata, Kazuyoshi Saito, Masanobu Ohishi, Hisaaki Miyahara, Shinya Tanaka, Koji Ishii, Hironobu Yoshimatsu and Yoshiya Tanaka

    Version of Record online : 25 MAY 2012, DOI: 10.1002/art.34329

  9. You have free access to this content
    Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients

    American Journal of Transplantation

    Volume 15, Issue 6, June 2015, Pages: 1644–1653, F. Vincenti, H. T. Silva, S. Busque, P. J. O'Connell, G. Russ, K. Budde, A. Yoshida, M. A. Tortorici, M. Lamba, N. Lawendy, W. Wang and G. Chan

    Version of Record online : 3 FEB 2015, DOI: 10.1111/ajt.13181

  10. You have full text access to this OnlineOpen article
    Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

    British Journal of Dermatology

    Volume 173, Issue 4, October 2015, Pages: 949–961, K.A. Papp, M.A. Menter, M. Abe, B. Elewski, S.R. Feldman, A.B. Gottlieb, R. Langley, T. Luger, D. Thaci, M. Buonanno, P. Gupta, J. Proulx, S. Lan, R. Wolk and for the OPT Pivotal 1 and OPT Pivotal 2 investigators

    Version of Record online : 29 OCT 2015, DOI: 10.1111/bjd.14018

  11. You have free access to this content
    Tofacitinib Facilitates the Expansion of Myeloid-Derived Suppressor Cells and Ameliorates Arthritis in SKG Mice

    Arthritis & Rheumatology

    Volume 67, Issue 4, April 2015, Pages: 893–902, Keisuke Nishimura, Jun Saegusa, Fumichika Matsuki, Kengo Akashi, Goichi Kageyama and Akio Morinobu

    Version of Record online : 27 MAR 2015, DOI: 10.1002/art.39007

  12. Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

    British Journal of Dermatology

    Volume 172, Issue 5, May 2015, Pages: 1395–1406, R. Bissonnette, L. Iversen, H. Sofen, C.E.M. Griffiths, P. Foley, R. Romiti, M. Bachinsky, S.T. Rottinghaus, H. Tan, J. Proulx, H. Valdez, P. Gupta, L. Mallbris and R. Wolk

    Version of Record online : 2 APR 2015, DOI: 10.1111/bjd.13551

  13. Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 2, March/April 2015, Pages: 83–88, Sriram Krishnaswami, Mary Boy, Vincent Chow and Gary Chan

    Version of Record online : 5 DEC 2014, DOI: 10.1002/cpdd.171

  14. You have full text access to this OnlineOpen article
    Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 109–115, Pankaj Gupta, Christine Alvey, Rong Wang, Martin E. Dowty, Odette A. Fahmi, Robert L. Walsky, Richard J. Riese and Sriram Krishnaswami

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04168.x

  15. Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 668–677, K.A. Papp, A. Menter, B. Strober, R.G. Langley, M. Buonanno, R. Wolk, P. Gupta, S. Krishnaswami, H. Tan and J.A. Harness

    Version of Record online : 27 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11168.x

  16. You have free access to this content
    JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

    Arthritis & Rheumatism

    Volume 64, Issue 11, November 2012, Pages: 3531–3542, Timothy P. LaBranche, Michael I. Jesson, Zaher A. Radi, Chad E. Storer, Julia A. Guzova, Sheri L. Bonar, Janice M. Thompson, Fernando A. Happa, Zachary S. Stewart, Yutian Zhan, Chris S. Bollinger, Prashant N. Bansal, Jeremy W. Wellen, Dean P. Wilkie, Steven A. Bailey, Peter T. Symanowicz, Martin Hegen, Richard D. Head, Nandini Kishore, Gabriel Mbalaviele and Debra M. Meyer

    Version of Record online : 27 OCT 2012, DOI: 10.1002/art.34649

  17. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi, Olivier Chosidow and Laurence Le Cleach

    Published Online : 22 DEC 2017, DOI: 10.1002/14651858.CD011535.pub2

  18. Small Molecules in the Treatment of Psoriasis

    Drug Development Research

    Volume 76, Issue 5, August 2015, Pages: 215–227, Tiago Torres and Paulo Filipe

    Version of Record online : 9 AUG 2015, DOI: 10.1002/ddr.21263

  19. Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteers

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 5, September/October 2015, Pages: 395–399, Sriram Krishnaswami, Tao Wang, Yi Yuan, Christine W. Alvey, Tina Checchio, Mark Peterson, Haihong Shi and Richard Riese

    Version of Record online : 16 JUL 2015, DOI: 10.1002/cpdd.202

  20. Novel Hinge-Binding Motifs for Janus Kinase 3 Inhibitors: A Comprehensive Structure–Activity Relationship Study on Tofacitinib Bioisosteres

    ChemMedChem

    Volume 9, Issue 11, November 2014, Pages: 2516–2527, Matthias Gehringer, Michael Forster, Ellen Pfaffenrot, Silke M. Bauer and Prof. Dr. Stefan A. Laufer

    Version of Record online : 19 AUG 2014, DOI: 10.1002/cmdc.201402252